SIGA TECHNOLOGIES INC
SIGANASDAQ🏆 #3522 by market capUS Equity
$3.18▼ $0.13 (−4.07%)
Market closed · at closeTrack SIGA
Get earnings, price moves & breaking news on Telegram
24h▼ 4.1%
7d▲ 1.9%
14d▲ 0.3%
30d▼ 7.0%
ytd▼ 47.9%
1y▼ 61.7%
🏦Market Cap
$228M
Small Cap
📈Revenue Growth (YoY)
-70.1%
Declining
📊Gross Margin
54.4%
Healthy
💵FCF Margin
28.3%
Strong
⚖️P/S Ratio
4.2x
Fair
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $3.07 – $3.32
- 52-Week Range
- $2.83 – $8.54
- Volume (shares)
- 37,843
- Avg Volume (shares)
- —
- Shares Outstanding
- 71.8M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- $95M
- Last Q Revenue
- $41M
- P/E Ratio
- —
- P/S Ratio
- 4.2x
- EPS (TTM)
- $-0.04
- Dividend Yield
- 19.21%
- Dilution (1yr)
- −0.2%
SIGA TECHNOLOGIES INC
SIGAFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$95M▼ −31.8% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
68.6%▼ −11.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$24M▼ −66.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$43M▼ −11.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
71.6M▼ −0.2% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$154M▼ −$482K YoY
StockOtter · stockotter.spaceAbout SIGA TECHNOLOGIES INC
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.